On February 27, 2003, one of the participants in a European scientific meeting held on February 14 and 15, 2003, in Lyon reported to the event organizer that four participants, including...

The current epidemiological situation regarding tuberculosis in France calls for a reassessment of the appropriateness of the BCG vaccination policy. Indeed, it closely aligns with the...

In July 2000, an amendment to the Public Health Code lifted the requirement to report sexually transmitted diseases (Ordinance 2000-548 of June 15, 2000). In late November 2000, a...

In France, between 2003 and 2006, 56 botulism outbreaks involving 96 patients were reported. Type B botulism was the most common (79% of the 68 confirmed cases). The source of the...

Following the reemergence of West Nile virus (WNV) in the Camargue in September 2000, a multi-species surveillance program was implemented in 2001 across the three departments of the...

Introduction. In France, surveillance of hepatitis C screening activities has been conducted since 2000 by a network of volunteer laboratories (Rena-VHC). To assess the...

Dengue and chikungunya are two arboviruses that circulated extensively in 2006 in the French overseas departments, with dengue affecting the Caribbean region and chikungunya the Indian...

Objective. This study describes mortality associated with chronic obstructive pulmonary disease (COPD) in France using multiple causes of death. Methods. The analysis focused on deaths...

Given its epidemic potential, its potential severity in adults, and the availability of an effective vaccine, hepatitis A warranted a national surveillance system. In November 2005,...

Introduction - The significant increase in international travel exposes a growing portion of the French population to health risks—whether infectious or otherwise—that can sometimes...